Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm


Journal article


María A García, Paula Barreras, A. Lewis, G. Pinilla, L. Sokoll, T. Kickler, H. Mostafa, Mario Caturegli, A. Moghekar, K. Fitzgerald, C. Pardo
Journal of Neurological Sciences, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
García, M. A., Barreras, P., Lewis, A., Pinilla, G., Sokoll, L., Kickler, T., … Pardo, C. (2021). Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. Journal of Neurological Sciences.


Chicago/Turabian   Click to copy
García, María A, Paula Barreras, A. Lewis, G. Pinilla, L. Sokoll, T. Kickler, H. Mostafa, et al. “Cerebrospinal Fluid in COVID-19 Neurological Complications: Neuroaxonal Damage, Anti-SARS-Cov2 Antibodies but No Evidence of Cytokine Storm.” Journal of Neurological Sciences (2021).


MLA   Click to copy
García, María A., et al. “Cerebrospinal Fluid in COVID-19 Neurological Complications: Neuroaxonal Damage, Anti-SARS-Cov2 Antibodies but No Evidence of Cytokine Storm.” Journal of Neurological Sciences, 2021.


BibTeX   Click to copy

@article{mar2021a,
  title = {Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm},
  year = {2021},
  journal = {Journal of Neurological Sciences},
  author = {García, María A and Barreras, Paula and Lewis, A. and Pinilla, G. and Sokoll, L. and Kickler, T. and Mostafa, H. and Caturegli, Mario and Moghekar, A. and Fitzgerald, K. and Pardo, C.}
}



Tools
Translate to